Abstract
The French Drug Agency is responsible for the control and delivery of batch release certificates. In the case of an influenza pandemic, the use of inactivated vaccines, produced according to well-established procedures and controlled according to the European Pharmacopea and FDA requirements, will be strictly dependent on the necessary delays for production and controls. Mutual recognition between the National Control Laboratories in Europe might help in shortening the delays. If new, inactivated vaccines are produced either on cell cultures or by using genetically modified organisms, and if live attenuated vaccines are needed, it would be suitable to organize ad hoc working groups and international collaborative studies in fields of both research and regulation.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Glezen WP, Taber LH, Gruber WC, et al. Family studies of vaccine efficacy in children: Comparison of protection provided by inactivated and attenuated influenza vaccines. In: Hannoun C, Kendal AP, Klenk HD, Ruben FL, eds. Options for the control Influenza II. Amsterdam: Excerpta Medica, 1993: 435–437.
Karzon DT. Cold adapted live vaccines: Conclusions and recommandations. In: Hannoun C, Kendal AP, Klenk HD, Ruben FL, eds. Options for the control Influenza II. Amsterdam: Excerpta Medica, 1993: 445–448.
Neustadt RE, Fineberg HV. ‘The Swine Flu Affair’ 1978. Washington, DC: US Department of Health Education and Welfare Publications, 1993.
Odelin MF, Pozzetto B, Aymard M, et al. Role of influenza vaccination in the elderly during an epidemic of A H1N1 virus in 1988–1989: Clinical and serological data. Gerontology 1993; 39: 109–116.
World Health Organization. Progress in the development of influenza vaccines: Memorandum from a WHO meeting — 1987. Bull WHO 1987; 65 (3): 289–293.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Aymard, M., Cano, JP. Role of the French drug licensing authority in the prevention of influenza pandemics. Eur J Epidemiol 10, 507–508 (1994). https://doi.org/10.1007/BF01719689
Issue Date:
DOI: https://doi.org/10.1007/BF01719689